Back
Sangamo Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
SGMO
Sangamo Therapeutics
Last Price:
$0.66
Seasonality Move:
-3.22%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and SGMO is experiencing slight selling pressure.
Sangamo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.71 | Sell |
| 20-day SMA: | 0.84 | Sell |
| 50-day SMA: | 1 | Sell |
| 200-day SMA: | 1.16 | Sell |
| 8-day EMA: | 0.7 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 1.01 | Sell |
| 200-day EMA: | 1.17 | Sell |
Sangamo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 35.23 | Sell |
| Chaikin Money Flow: | -12120901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.73 - 0.99) | Sell |
| Bollinger Bands (100): | (0.85 - 2.13) | Sell |
Sangamo Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.66 while SGMO 8-day simple moving average is 0.71, which is a Sell signal.
-
The stock price of SGMO is 0.66 while Sangamo Therapeutics 20-day SMA is 0.84, which makes it a Sell.
-
Sangamo Therapeutics 50-day simple moving average is 1.00 while SGMO share price is 0.66, making it a Sell technically.
-
SGMO stock price is 0.66 and Sangamo Therapeutics 200-day simple moving average is 1.16, creating a Sell signal.
SGMO Technical Analysis vs Fundamental Analysis
Sell
18
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a SellThe current Sangamo Therapeutics [SGMO] share price is $0.66. The Score for SGMO is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
147.5M
Price in USD:
0.66
Share Volume:
57M
Sangamo Therapeutics 52-Week Range
52-Week High:
3.18
52-Week Low:
0.30
Sell
18
Sangamo Therapeutics (SGMO)
is a Sell
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?The Sangamo Therapeutics stock price is 0.66 USD today.
-
Will SGMO stock go up or go down?Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sangamo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is overvalued.
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.66 while SGMO 8-day exponential moving average is 0.70, which is a Sell signal.
-
The stock price of SGMO is 0.66 while Sangamo Therapeutics 20-day EMA is 0.81, which makes it a Sell.
-
Sangamo Therapeutics 50-day exponential moving average is 1.01 while SGMO share price is 0.66, making it a Sell technically.
-
SGMO stock price is 0.66 and Sangamo Therapeutics 200-day simple moving average is 1.17, creating a Sell signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
-
SGMO Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Sangamo Therapeutics is a Sell
-
Sangamo Therapeutics Relative Strength Index (RSI) is 35.23, which suggest Sangamo Therapeutics is oversold
-
The Bollinger Bands (25) for Sangamo Therapeutics is (0.73 - 0.99), which suggest Sangamo Therapeutics is a Sell
-
The Bollinger Bands (100) for Sangamo Therapeutics is (0.85 - 2.13), which suggest Sangamo Therapeutics is a Sell
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.